SNOA financials
Sonoma Pharmaceuticals (SNOA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- SNOA revenue was $19.53M in fiscal 2026, net income -$3.17M.
SNOA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $19.53M | $7.42M | -$2.46M | -$3.17M | -0.38 |
| 2025 | $14.29M | $5.46M | -$3.71M | -$3.46M | -0.56 |
| 2024 | $12.73M | $4.75M | -$4.70M | -$4.83M | -2.13 |
| 2023 | $13.27M | $4.48M | -$4.57M | -$5.15M | -6.08 |
| 2022 | $12.63M | $3.99M | -$5.89M | -$5.09M | -7.68 |
| 2021 | $18.63M | $6.56M | -$3.45M | -$3.95M | -7.88 |